awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33718025-7D62FC1F-1785-4929-8A24-0CFC967CE90C
Q33718025-7D62FC1F-1785-4929-8A24-0CFC967CE90C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33718025-7D62FC1F-1785-4929-8A24-0CFC967CE90C
Molecular mechanisms of resistance to tumour anti-angiogenic strategies
P2860
Q33718025-7D62FC1F-1785-4929-8A24-0CFC967CE90C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33718025-7D62FC1F-1785-4929-8A24-0CFC967CE90C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
021a0216afda0c9d2a4460d26e2e7ae99898ab58
P2860
Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer.